The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insulin Drug and Delivery Technologies-Global Market Insights and Sales Trends 2024
Synopsis
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The global Insulin Drug and Delivery Technologies market size is expected to reach US$ 61720 million by 2029, growing at a CAGR of 9.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Drug and Delivery Technologies in various end use industries. The expanding demands from the Diabetes Mellitus Type 1, Diabetes Mellitus Type 2 and Gestational Diabetes,, are propelling Insulin Drug and Delivery Technologies market. Insulin Syringes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Vials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Drug and Delivery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Drug and Delivery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Drug and Delivery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Drug and Delivery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Drug and Delivery Technologies covered in this report include Sanofi, Eli Lilly and Company, Biocon, Julphar, Ypsomed and Becton, Dickinson and Company, etc.
The global Insulin Drug and Delivery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Global Insulin Drug and Delivery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Drug and Delivery Technologies market, Segment by Type:
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Global Insulin Drug and Delivery Technologies market, by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Drug and Delivery Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The global Insulin Drug and Delivery Technologies market size is expected to reach US$ 61720 million by 2029, growing at a CAGR of 9.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Drug and Delivery Technologies in various end use industries. The expanding demands from the Diabetes Mellitus Type 1, Diabetes Mellitus Type 2 and Gestational Diabetes,, are propelling Insulin Drug and Delivery Technologies market. Insulin Syringes, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Vials segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Drug and Delivery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Drug and Delivery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Drug and Delivery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Drug and Delivery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Drug and Delivery Technologies covered in this report include Sanofi, Eli Lilly and Company, Biocon, Julphar, Ypsomed and Becton, Dickinson and Company, etc.
The global Insulin Drug and Delivery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Global Insulin Drug and Delivery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Drug and Delivery Technologies market, Segment by Type:
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Global Insulin Drug and Delivery Technologies market, by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Drug and Delivery Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Insulin Drug and Delivery Technologies Market Overview
1.1 Insulin Drug and Delivery Technologies Product Overview
1.2 Insulin Drug and Delivery Technologies Market Segment by Type
1.2.1 Insulin Syringes
1.2.2 Insulin Vials
1.2.3 Insulin Pens
1.2.4 Insulin Pumps
1.3 Global Insulin Drug and Delivery Technologies Market Size by Type
1.3.1 Global Insulin Drug and Delivery Technologies Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Drug and Delivery Technologies Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Drug and Delivery Technologies Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Drug and Delivery Technologies Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Drug and Delivery Technologies Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Drug and Delivery Technologies Sales Breakdown by Type (2018-2023)
2 Global Insulin Drug and Delivery Technologies Market Competition by Company
2.1 Global Top Players by Insulin Drug and Delivery Technologies Sales (2018-2023)
2.2 Global Top Players by Insulin Drug and Delivery Technologies Revenue (2018-2023)
2.3 Global Top Players by Insulin Drug and Delivery Technologies Price (2018-2023)
2.4 Global Top Manufacturers Insulin Drug and Delivery Technologies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Drug and Delivery Technologies Market Competitive Situation and Trends
2.5.1 Insulin Drug and Delivery Technologies Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Drug and Delivery Technologies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Drug and Delivery Technologies as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Drug and Delivery Technologies Market
2.8 Key Manufacturers Insulin Drug and Delivery Technologies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Drug and Delivery Technologies Status and Outlook by Region
3.1 Global Insulin Drug and Delivery Technologies Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Drug and Delivery Technologies Historic Market Size by Region
3.2.1 Global Insulin Drug and Delivery Technologies Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Drug and Delivery Technologies Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Drug and Delivery Technologies Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Region
3.3.1 Global Insulin Drug and Delivery Technologies Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Drug and Delivery Technologies Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Drug and Delivery Technologies Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Drug and Delivery Technologies by Application
4.1 Insulin Drug and Delivery Technologies Market Segment by Application
4.1.1 Diabetes Mellitus Type 1
4.1.2 Diabetes Mellitus Type 2
4.1.3 Gestational Diabetes
4.2 Global Insulin Drug and Delivery Technologies Market Size by Application
4.2.1 Global Insulin Drug and Delivery Technologies Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Drug and Delivery Technologies Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Drug and Delivery Technologies Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Drug and Delivery Technologies Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Drug and Delivery Technologies Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Drug and Delivery Technologies Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Drug and Delivery Technologies Sales Breakdown by Application (2018-2023)
5 North America Insulin Drug and Delivery Technologies by Country
5.1 North America Insulin Drug and Delivery Technologies Historic Market Size by Country
5.1.1 North America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Drug and Delivery Technologies Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Drug and Delivery Technologies Sales in Value by Country (2018-2023)
5.2 North America Insulin Drug and Delivery Technologies Forecasted Market Size by Country
5.2.1 North America Insulin Drug and Delivery Technologies Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Drug and Delivery Technologies Sales in Value by Country (2024-2029)
6 Europe Insulin Drug and Delivery Technologies by Country
6.1 Europe Insulin Drug and Delivery Technologies Historic Market Size by Country
6.1.1 Europe Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Drug and Delivery Technologies Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Drug and Delivery Technologies Sales in Value by Country (2018-2023)
6.2 Europe Insulin Drug and Delivery Technologies Forecasted Market Size by Country
6.2.1 Europe Insulin Drug and Delivery Technologies Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Drug and Delivery Technologies Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Drug and Delivery Technologies by Region
7.1 Asia-Pacific Insulin Drug and Delivery Technologies Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Drug and Delivery Technologies Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Drug and Delivery Technologies Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Drug and Delivery Technologies Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Drug and Delivery Technologies Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Drug and Delivery Technologies Sales in Value by Region (2024-2029)
8 Latin America Insulin Drug and Delivery Technologies by Country
8.1 Latin America Insulin Drug and Delivery Technologies Historic Market Size by Country
8.1.1 Latin America Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Drug and Delivery Technologies Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Drug and Delivery Technologies Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Drug and Delivery Technologies Forecasted Market Size by Country
8.2.1 Latin America Insulin Drug and Delivery Technologies Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Drug and Delivery Technologies Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Drug and Delivery Technologies by Country
9.1 Middle East and Africa Insulin Drug and Delivery Technologies Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Drug and Delivery Technologies Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Drug and Delivery Technologies Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Drug and Delivery Technologies Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Insulin Drug and Delivery Technologies Products Offered
10.1.5 Sanofi Recent Development
10.2 Eli Lilly and Company
10.2.1 Eli Lilly and Company Company Information
10.2.2 Eli Lilly and Company Introduction and Business Overview
10.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Products Offered
10.2.5 Eli Lilly and Company Recent Development
10.3 Biocon
10.3.1 Biocon Company Information
10.3.2 Biocon Introduction and Business Overview
10.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Biocon Insulin Drug and Delivery Technologies Products Offered
10.3.5 Biocon Recent Development
10.4 Julphar
10.4.1 Julphar Company Information
10.4.2 Julphar Introduction and Business Overview
10.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Julphar Insulin Drug and Delivery Technologies Products Offered
10.4.5 Julphar Recent Development
10.5 Ypsomed
10.5.1 Ypsomed Company Information
10.5.2 Ypsomed Introduction and Business Overview
10.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ypsomed Insulin Drug and Delivery Technologies Products Offered
10.5.5 Ypsomed Recent Development
10.6 Becton, Dickinson and Company
10.6.1 Becton, Dickinson and Company Company Information
10.6.2 Becton, Dickinson and Company Introduction and Business Overview
10.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Products Offered
10.6.5 Becton, Dickinson and Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Drug and Delivery Technologies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Drug and Delivery Technologies Industrial Chain Analysis
11.4 Insulin Drug and Delivery Technologies Market Dynamics
11.4.1 Insulin Drug and Delivery Technologies Industry Trends
11.4.2 Insulin Drug and Delivery Technologies Market Drivers
11.4.3 Insulin Drug and Delivery Technologies Market Challenges
11.4.4 Insulin Drug and Delivery Technologies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Drug and Delivery Technologies Distributors
12.3 Insulin Drug and Delivery Technologies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
